“…Alternative methods for measurement of platelet activation in human patients with systemic inflammatory diseases (i.e., sepsis, SIRS, MODS) include whole blood impedance aggregometry (multiplate analyzer), 1,17 measurement of soluble forms of platelet membrane glycoproteins (i.e., sPselectin and sCD40L) with ELISAs, 11,18,19,40,51 and also using ELISA measurements of platelet-specific molecules released from platelet granules during activation (i.e., platelet factor 4, microparticles, microparticle-associated tissue factor, βthromboglobulin). 41,52,58,69 Whole blood impedance aggregometry (multiplate analyzer) is a point-of-care test and was evaluated in the same cohort of equids as our study, but there were no significant differences in aggregation values between SIRS cases and controls. 21 Similarly, the soluble form of glycoproteins CD40L and CD62P could not be quantified in equine plasma samples using commercial human ELISAs.…”